Viengthong Pharma (VTP), a leading pharmaceutical distributor in Vientiane, Laos, is driving a significant transformation in the healthcare sector for young people living with Type 1 Diabetes (T1D). In partnership with Action4Diabetes (A4D), VTP proudly marks the arrival of the second shipment of life-saving insulin provided by Eli Lilly and Company, a leading global medicine company, through Direct Relief.
Building on the success of the first shipment in 2023, this latest delivery underscores the ongoing commitment of Lilly, Direct Relief, A4D, and VTP to ensure sustained access to essential medicines for youth living with T1D in Laos.
The provided insulin embarked on a carefully coordinated journey from the Netherlands to Bangkok before arriving at VTP's advanced warehouse in Vientiane. VTP’s renowned expertise in logistics and cold chain management was instrumental in maintaining the medicine’s integrity throughout the complex supply chain.
Mr. Sihamano Bannavong, CEO of Viengthong Pharma, emphasized the company's commitment to quality, stating, "Our GSDP-certified warehouse ensures that medicines like this life-saving insulin are stored and handled according to the highest international standards. This collaboration truly reflects our mission to uplift the lives of Lao children, who represent the future of our nation. It's this very mission that motivates me and every Viengthong Pharma employee to strive for excellence every day."
VTP's role extends far beyond the importation of insulin. VTP has been instrumental in improving healthcare access across Laos by ensuring that the medicine is delivered promptly to hospitals and clinics participating in A4D’s programme. These efforts are critical in a country where healthcare infrastructure is still evolving and timely access to medication can mean the difference between life and death for individuals living with chronic conditions such as T1D.
The continued success of this initiative is a testament to VTP’s leadership in the healthcare sector in Laos. With the support of such global organisations as Lilly, Direct Relief and A4D, VTP has not only enhanced access to essential medications but also set new standards for healthcare delivery in the country. Their efforts are helping to build a more resilient healthcare system, capable of meeting the needs of the Lao people, particularly those in vulnerable communities.
VTP remains at the forefront of expanding healthcare access in Laos, exemplifying how local expertise and dedication can drive profound and lasting progress.
תגובות